These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22641382)

  • 1. Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.
    McCoy LE; Quigley AF; Strokappe NM; Bulmer-Thomas B; Seaman MS; Mortier D; Rutten L; Chander N; Edwards CJ; Ketteler R; Davis D; Verrips T; Weiss RA
    J Exp Med; 2012 Jun; 209(6):1091-103. PubMed ID: 22641382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
    Strokappe N; Szynol A; Aasa-Chapman M; Gorlani A; Forsman Quigley A; Hulsik DL; Chen L; Weiss R; de Haard H; Verrips T
    PLoS One; 2012; 7(3):e33298. PubMed ID: 22438910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.
    McCoy LE; Rutten L; Frampton D; Anderson I; Granger L; Bashford-Rogers R; Dekkers G; Strokappe NM; Seaman MS; Koh W; Grippo V; Kliche A; Verrips T; Kellam P; Fassati A; Weiss RA
    PLoS Pathog; 2014 Dec; 10(12):e1004552. PubMed ID: 25522326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.
    Forsman A; Beirnaert E; Aasa-Chapman MM; Hoorelbeke B; Hijazi K; Koh W; Tack V; Szynol A; Kelly C; McKnight A; Verrips T; de Haard H; Weiss RA
    J Virol; 2008 Dec; 82(24):12069-81. PubMed ID: 18842738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
    Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
    J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J
    J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
    Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
    PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
    Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.
    Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL
    Front Immunol; 2020; 11():984. PubMed ID: 32582155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.
    Ringe R; Thakar M; Bhattacharya J
    Retrovirology; 2010 Sep; 7():76. PubMed ID: 20860805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization.
    Phad GE; Vázquez Bernat N; Feng Y; Ingale J; Martinez Murillo PA; O'Dell S; Li Y; Mascola JR; Sundling C; Wyatt RT; Karlsson Hedestam GB
    J Immunol; 2015 Jun; 194(12):5903-14. PubMed ID: 25964491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
    Liao HX; Tsao CY; Alam SM; Muldoon M; Vandergrift N; Ma BJ; Lu X; Sutherland LL; Scearce RM; Bowman C; Parks R; Chen H; Blinn JH; Lapedes A; Watson S; Xia SM; Foulger A; Hahn BH; Shaw GM; Swanstrom R; Montefiori DC; Gao F; Haynes BF; Korber B
    J Virol; 2013 Apr; 87(8):4185-201. PubMed ID: 23365441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.
    McGuire AT; Hoot S; Dreyer AM; Lippy A; Stuart A; Cohen KW; Jardine J; Menis S; Scheid JF; West AP; Schief WR; Stamatatos L
    J Exp Med; 2013 Apr; 210(4):655-63. PubMed ID: 23530120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
    Yuan T; Li J; Zhang MY
    MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.